Re-establishment of normal radioactive iodine uptake reference range in the era of universal salt iodization in the Indian population

by Sanjana Ballal, Ramya Soundararajan, Chandrasekhar Bal
Published 2017-01-01

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

by Madhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal
Published 2019-02-01

Stunning in post 131 I therapy scans after low-dose 131 I diagnostic whole body scans with differentiated thyroid cancer in the Indian patient population: Critical importance of in...

by Nishikant A Damle, Chandrasekhar Bal, Sanjana Ballal
Published 2012-01-01

[177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results

by Madhav Prasad Yadav, Sanjana Ballal, Marian Meckel, Frank Roesch, Chandrasekhar Bal
Published 2020-10-01

Comparison of clinical outcome after a fixed dose versus dosimetry-based radioiodine treatment of Graves′ disease: Results of a randomized controlled trial in Indian population

by Abhishek Kumar Jaiswal, Chandrasekhar Bal, Nishikant Avinash Damle, Sanjana Ballal, Ravinder Goswami, Smriti Hari, Praveen Kumar
Published 2014-01-01

Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients.

by Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, Madhavi Tripathi, Nishikant Avinash Damle, Shamim Ahmed Shamim, Rakesh Kumar, Amlesh Seth, Chandrasekhar Bal
Published 2021-01-01